Bionano Genomics, Inc. - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
BNGO Nasdaq 8081 bionano.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bionano Genomics, Inc.

Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia - Sep 14th, 2026 7:00 am
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - Sep 10th, 2026 7:00 am
Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping - Sep 8th, 2026 7:00 am
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Aug 24th, 2026 6:00 am
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - Aug 17th, 2026 3:14 pm
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ... - Aug 10th, 2026 11:03 pm
Bionano Genomics, Inc. Q2 2026 Earnings Call Summary - Aug 10th, 2026 6:59 pm
Bionano Reports Second Quarter 2026 Results and Provides a Business Update - Aug 10th, 2026 2:05 pm
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026 - Jul 27th, 2026 2:05 pm
Nabsys Appoints Genome Mapping Pioneer Alka Chaubey, Ph.D., as Chief Medical and Genomics Officer - Jul 6th, 2026 6:00 am
Bionano Announces Hiring of Chief Scientific Officer - Jun 24th, 2026 6:30 am
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption - Jun 18th, 2026 6:00 am
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders - Jun 11th, 2026 6:00 am
Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock? - Jun 8th, 2026 10:00 am
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors - May 28th, 2026 6:55 am
Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures - May 28th, 2026 6:00 am
Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia - May 26th, 2026 6:00 am
Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder - May 20th, 2026 2:51 pm